Godsey & Gibb Inc’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3K Sell
208
-24
-10% -$372 ﹤0.01% 335
2026
Q1
$3.13K Hold
232
﹤0.01% 335
2025
Q4
$2.89K Hold
232
﹤0.01% 378
2025
Q3
$2.3K Hold
232
﹤0.01% 337
2025
Q2
$2.07K Hold
232
﹤0.01% 324
2025
Q1
$2.02K Hold
232
﹤0.01% 356
2024
Q4
$2.89K Hold
232
﹤0.01% 326
2024
Q3
$2.69K Hold
232
﹤0.01% 392
2024
Q2
$2.47K Sell
232
-14
-6% -$155 ﹤0.01% 367
2024
Q1
$2.94K Buy
246
+13
+6% +$157 ﹤0.01% 336
2023
Q4
$2.52K Buy
233
+1
+0.4% +$10 ﹤0.01% 323
2023
Q3
$2.29K Hold
232
﹤0.01% 301
2023
Q2
$2.32K Hold
232
﹤0.01% 331
2023
Q1
$2.23K Sell
232
-100
-30% -$1.11K ﹤0.01% 303
2022
Q4
$3.69K Buy
+332
New +$3.47K ﹤0.01% 241

Other funds holding VTRS

Godsey & Gibb Inc's VTRS Position: Q2 2026 in Review

Godsey & Gibb Inc reduced its Viatris (VTRS) stake by 10% in Q2 2026, selling an estimated $372 and leaving 208 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Godsey & Gibb Inc first reported a position in VTRS in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.69K in Q4 2022. 516 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Godsey & Gibb Inc held 208 shares of Viatris worth $3.3K as of Q2 2026.
  • Godsey & Gibb Inc sold 24 Viatris shares in Q2 2026, an estimated $372.
  • Viatris made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #335 holding.
  • Godsey & Gibb Inc first reported a position in Viatris in Q4 2022 and has held it in 15 quarters since.
  • Godsey & Gibb Inc's Viatris position peaked at $3.69K in Q4 2022.
  • 516 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.